| RS2149390170 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2149390330 |
PPP2CA
|
Health Risk |
Pathogenic |
— |
| RS2149390347 |
PPP2CA
|
Health Risk |
Pathogenic |
— |
| RS2149390365 |
PPP2CA
|
Health Risk |
Pathogenic |
— |
| RS2149393215 |
DOCK7
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2149393749 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2149397188 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149397518 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149397818 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149398883 |
MOCS1
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS2149398895 |
MOCS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS2149401562 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149402360 |
ANO10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2149404327 |
RYR2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy |
| RS2149407830 |
PROM1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 41, Retinitis pigmentosa 41 |
| RS2149409476 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149413101 |
BLTP1
|
Health Risk |
Pathogenic |
Alkuraya-Kucinskas syndrome, Alkuraya-Kucinskas syndrome |
| RS2149415255 |
MYO6
|
Health Risk |
Pathogenic |
— |
| RS2149416563 |
COL12A1
|
Health Risk |
Likely pathogenic |
— |
| RS2149419438 |
MOCS1
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS2149419593 |
MOCS1
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS2149419668 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149419886 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149424269 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2149424713 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149429492 |
MOCS1
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A |
| RS2149433604 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149436201 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS2149437479 |
RYR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2149437622 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2149437640 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2149437719 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2149439433 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2149441532 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149449522 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149449539 |
DEPDC5
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2149449670 |
DEPDC5
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial focal epilepsy with variable foci, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS2149449730 |
DEPDC5
|
Health Risk |
Pathogenic |
— |
| RS2149457526 |
IMPG1
|
Health Risk |
Pathogenic |
— |
| RS2149463584 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149463861 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149466212 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149468435 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149468550 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS2149468567 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149477595 |
IMPG1
|
Health Risk |
Likely pathogenic |
— |
| RS2149478420 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS2149480454 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149480893 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2149480897 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2149480970 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149481901 |
ANO10
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 10, Autosomal recessive spinocerebellar ataxia 10 |
| RS2149482319 |
IMPG1
|
Health Risk |
Pathogenic |
Vitelliform macular dystrophy 4, Retinal dystrophy |
| RS2149482320 |
IMPG1
|
Health Risk |
Pathogenic |
— |
| RS2149482408 |
IMPG1
|
Health Risk |
Likely pathogenic |
— |
| RS2149487756 |
SLC5A1
|
Health Risk |
Likely pathogenic |
Congenital glucose-galactose malabsorption, Congenital glucose-galactose malabsorption |
| RS2149489346 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS2149489382 |
LRBA
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS2149492081 |
MYT1L
|
Health Risk |
Pathogenic |
— |
| RS2149492476 |
SLC5A1
|
Health Risk |
Likely pathogenic |
Congenital glucose-galactose malabsorption, Congenital glucose-galactose malabsorption |
| RS2149492561 |
COL12A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS2149493164 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149493395 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2149494307 |
WDFY3
|
Health Risk |
Pathogenic |
Microcephaly 18, primary |
| RS2149496680 |
SLC5A1
|
Health Risk |
Pathogenic |
Congenital glucose-galactose malabsorption, Congenital glucose-galactose malabsorption |
| RS2149499164 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2149501551 |
FNIP1
|
Health Risk |
Pathogenic |
Immunodeficiency 93 and hypertrophic cardiomyopathy, Immunodeficiency 93 and hypertrophic cardiomyopathy |
| RS2149504053 |
FNIP1
|
Health Risk |
Pathogenic |
Immunodeficiency 93 and hypertrophic cardiomyopathy, Immunodeficiency 93 and hypertrophic cardiomyopathy |
| RS2149504123 |
FNIP1
|
Health Risk |
Pathogenic |
Immunodeficiency 93 and hypertrophic cardiomyopathy, Immunodeficiency 93 and hypertrophic cardiomyopathy |
| RS2149508258 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS2149508349 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS2149508421 |
LRBA
|
Health Risk |
Likely pathogenic |
— |
| RS2149510283 |
NIPBL
|
Health Risk |
Likely pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental abnormality |
| RS2149518317 |
FNIP1
|
Health Risk |
Pathogenic |
Immunodeficiency 93 and hypertrophic cardiomyopathy, Immunodeficiency 93 and hypertrophic cardiomyopathy |
| RS2149518765 |
TBCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypotonia, infantile |
| RS2149520942 |
GRIA1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 67 |
| RS2149534097 |
FNIP1
|
Health Risk |
Pathogenic |
Immunodeficiency 93 and hypertrophic cardiomyopathy, Immunodeficiency 93 and hypertrophic cardiomyopathy |
| RS2149542191 |
CAMTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2149546596 |
MINAR2
|
Health Risk |
Pathogenic |
Hearing loss, autosomal recessive 120 |
| RS2149549124 |
NEK1
|
Health Risk |
Likely pathogenic |
— |
| RS2149558070 |
NEK1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS2149562896 |
PITX1
|
Health Risk |
Likely pathogenic |
Clubfoot, Clubfoot |
| RS2149568185 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149584157 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149585436 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS2149594548 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149595559 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149597479 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS2149602979 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS2149607039 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS2149607105 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS2149614206 |
APC
|
Health Risk |
Likely pathogenic |
Carcinoma of colon, Hereditary cancer-predisposing syndrome |
| RS2149614301 |
APC
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS2149614389 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2149614665 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149614716 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149614987 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149615315 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2149615791 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2149616393 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |